Results 291 to 300 of about 1,463,832 (396)
TGF‐β inhibition is emerging as a promising cancer therapy, yet translating laboratory success to bedside implementation has suffered significant setbacks. The associated challenges include adverse drug reactions, inadequate predictive models, and activation of alternative signaling pathways.
Faizah A. Alabi+5 more
wiley +1 more source
Machine learning for predicting distant metastasis in nasopharyngeal carcinoma patients. [PDF]
Sun H+5 more
europepmc +1 more source
1048 Parotid gland sparing using inverse planning for radiotherapy of nasopharyngeal carcinomas
Kenneth Forster+13 more
openalex +1 more source
Abstract Background Studies suggest that integrating robust planning and noncoplanar volumetric modulated arc therapy (VMAT) may be a useful strategy for maximizing the benefits of dose delivery while maintaining resilience to uncertainty; however, the robustness of target coverage and the dose‐sparing performance for organs at risk of techniques that ...
Kouta Hirotaki+6 more
wiley +1 more source
Capecitabine Maintenance Therapy in Patients with Residual Nasopharyngeal Carcinoma: A Single-Arm, Phase II Trial. [PDF]
Cao X+13 more
europepmc +1 more source
ABSTRACT Objective To investigate the correlation between peripheral blood CRP‐to‐lymphocyte ratio (CLR) and lactate dehydrogenase‐to‐albumin ratio (LAR) levels, prognosis, and the tumor microenvironment (TME) in patients with acral melanoma (AM), with a focus on tertiary lymphoid structures (TLS) and immune cell infiltration.
Donglin Kang+5 more
wiley +1 more source
[Retracted] Fisetin inhibits migration, invasion and epithelial‑mesenchymal transition of LMP1‑positive nasopharyngeal carcinoma cells. [PDF]
Li R, Zhao Y, Chen J, Shao S, Zhang X.
europepmc +1 more source